{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:31:10Z","timestamp":1789507870623,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondation Saint-Luc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Severe forms of coronavirus 2019 (COVID-19) disease are caused by an exaggerated systemic inflammatory response and subsequent inflammation-related coagulopathy. Anti-inflammatory treatment with low dose dexamethasone has been shown to reduce mortality in COVID-19 patients requiring oxygen therapy. However, the mechanisms of action of corticosteroids have not been extensively studied in critically ill patients in the context of COVID-19. Plasma biomarkers of inflammatory and immune responses, endothelial and platelet activation, neutrophil extracellular trap formation, and coagulopathy were compared between patients treated or not by systemic dexamethasone for severe forms of COVID-19. Dexamethasone treatment significantly reduced the inflammatory and lymphoid immune response in critical COVID-19 patients but had little effect on the myeloid immune response and no effect on endothelial activation, platelet activation, neutrophil extracellular trap formation, and coagulopathy. The benefits of low dose dexamethasone on outcome in critical COVID-19 can be partially explained by a modulation of the inflammatory response but not by reduction of coagulopathy. Future studies should explore the impact of combining dexamethasone with other immunomodulatory or anticoagulant drugs in severe COVID-19.<\/jats:p>","DOI":"10.3390\/ijms24087278","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T09:23:43Z","timestamp":1681464223000},"page":"7278","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill"],"prefix":"10.3390","volume":"24","author":[{"given":"M\u00e9lanie","family":"Dechamps","sequence":"first","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"},{"name":"Department of Cardiovascular Intensive Care, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"De Poortere","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Octave","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Ginion","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Robaux","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Pirotton","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bodart","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gruson","sequence":"additional","affiliation":[{"name":"Department of Clinical Biology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Astrid","family":"Van Dievoet","sequence":"additional","affiliation":[{"name":"Department of Clinical Biology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7644-5298","authenticated-orcid":false,"given":"Jonathan","family":"Douxfils","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Namur Research Institute for Life Sciences (Narilis), 5000 Namur, Belgium"},{"name":"Qualiblood, s.a., 5000 Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Haguet","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Namur Research Institute for Life Sciences (Narilis), 5000 Namur, Belgium"},{"name":"Qualiblood, s.a., 5000 Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-304X","authenticated-orcid":false,"given":"Laure","family":"Morimont","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Namur Research Institute for Life Sciences (Narilis), 5000 Namur, Belgium"},{"name":"Qualiblood, s.a., 5000 Namur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Derive","sequence":"additional","affiliation":[{"name":"Inotrem s.a., 54500 Vandoeuvre-les-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Jolly","sequence":"additional","affiliation":[{"name":"Inotrem s.a., 54500 Vandoeuvre-les-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-7099","authenticated-orcid":false,"given":"Luc","family":"Bertrand","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"},{"name":"Walloon Excellence in Life Sciences and Biotechnology (WELBIO) Department, WEL Research Institute, 1300 Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Laterre","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Centre Hospitalier Regional Mons-Hainaut, 7000 Mons, Belgium"},{"name":"Critical Care Coordinating Center (4Cs), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Horman","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[{"name":"P\u00f4le de Recherche Cardiovasculaire (CARD), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium"},{"name":"Department of Cardiology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155593","DOI":"10.1016\/j.cyto.2021.155593","article-title":"The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?","volume":"144","author":"Morris","year":"2021","journal-title":"Cytokine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3389\/fmed.2021.780750","article-title":"Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study","volume":"8","author":"Dechamps","year":"2022","journal-title":"Front. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"719023","DOI":"10.3389\/fimmu.2021.719023","article-title":"COVID-19 Immunobiology: Lessons Learned, New Questions Arise","volume":"12","author":"Kaklamanos","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11033-021-06793-0","article-title":"Corticosteroids for COVID-19: Worth it or not?","volume":"49","author":"Akter","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Ai, G., Chen, L., Liu, S., Gong, C., Zhu, X., Zhang, C., Qin, H., Hu, J., and Huang, J. (2021). Associations of immunological features with COVID-19 severity: A systematic review and meta-analysis. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06457-1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.120.048925","article-title":"Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19\u2013Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study","volume":"142","author":"Masi","year":"2020","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/SHK.0000000000001680","article-title":"A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy","volume":"55","author":"Goswami","year":"2020","journal-title":"Shock"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103812","DOI":"10.1016\/j.ebiom.2022.103812","article-title":"Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs","volume":"75","author":"Won","year":"2022","journal-title":"Ebiomedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103893","DOI":"10.1016\/j.ebiom.2022.103893","article-title":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients","volume":"77","author":"Montiel","year":"2022","journal-title":"Ebiomedicine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Morimont, L., Dechamps, M., David, C., Bouvy, C., Gillot, C., Haguet, H., Favresse, J., Ronvaux, L., Candiracci, J., and Herzog, M. (2022). NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules, 12.","DOI":"10.3390\/biom12081038"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis","volume":"29\u201330","author":"Malas","year":"2020","journal-title":"Eclinicalmedicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensiv. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-Immunomodulatory Therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Inspiration Investigators, Sadeghipour, P., Talasaz, A.H., Rashidi, F., Sharif-Kashani, B., Beigmohammadi, M.T., Farrokhpour, M., Sezavar, S.H., Payandemehr, P., and Dabbagh, A. (2021). Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA, 325, 1620.","DOI":"10.1001\/jama.2021.4152"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group (2021). Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"The Writing Committee for the REMAP-CAP Investigators, Angus, D.C., Derde, L., Al-Beidh, F., Annane, D., Arabi, Y., Beane, A., Van Bentum-Puijk, W., Berry, L., and Bhimani, Z. (2020). Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA, 324, 1317\u20131329.","DOI":"10.1001\/jama.2020.17022"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: A systematic review and meta-analysis on clinical outcomes","volume":"24","author":"Vos","year":"2020","journal-title":"Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J.A.C., Murthy, S., Diaz, J.V., Slutsky, A.S., Villar, J., Angus, D.C., Annane, D., Azevedo, L.C.P., and Berwanger, O. (2020). Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA, 324, 1330\u20131341.","DOI":"10.1001\/jama.2020.17023"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1503\/cmaj.200645","article-title":"Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: A systematic review and meta-analysis","volume":"192","author":"Ye","year":"2020","journal-title":"Can. Med. Assoc. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: Quintiles Prize Lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection Risk and Safety of Corticosteroid Use","volume":"42","author":"Youssef","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Asif, S., Frithiof, R., Larsson, A., Franz\u00e9n, S., Anderberg, S.B., Kristensen, B., Hultstr\u00f6m, M., and Lipcsey, M. (2023). Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19\u2014A Swedish Cohort Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010164"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1076029621993573","DOI":"10.1177\/1076029621993573","article-title":"Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis","volume":"27","author":"Sarfraz","year":"2021","journal-title":"Clin. Appl. Thromb."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mesland, J.-B., Carlier, E., Fran\u00e7ois, B., Serck, N., Gerard, L., Briat, C., Piagnerelli, M., Laterre, P.-F., and on behalf of the COVCORVAP Collaboration Group (2022). Early Corticosteroid Therapy May Increase Ventilator-Associated Lower Respiratory Tract Infection in Critically Ill Patients with COVID-19: A Multicenter Retrospective Cohort Study. Microorganisms, 10.","DOI":"10.3390\/microorganisms10050984"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T Cell Responses to Whole SARS Coronavirus in Humans","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy Findings and Venous Thromboembolism in Patients with COVID-19: A Prospective Cohort Study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: The vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: A retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.178.3.1845","article-title":"Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia","volume":"178","author":"Lemaire","year":"2007","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12931-022-02060-3","article-title":"Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward","volume":"23","author":"Michels","year":"2022","journal-title":"Respir. Res."},{"key":"ref_46","first-page":"48","article-title":"Impact of corticosteroids on the procoagulant profile of critically ill COVID-19 patients: A before-after study","volume":"89","author":"Gabarre","year":"2022","journal-title":"Minerva Anestesiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07853890.2020.1839959","article-title":"Hydroxychloroquine: A comprehensive review and its controversial role in coronavirus disease 2019","volume":"53","author":"Bansal","year":"2020","journal-title":"Ann. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jfma.2020.08.022","article-title":"Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics","volume":"120","author":"Liu","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_49","unstructured":"ARDS Definition of Task Force, Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., Fan, E., Camporota, L., and Slutsky, A.S. (2012). Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA, 307, 2526\u20132533."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","article-title":"The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation","volume":"37","author":"Jones","year":"2009","journal-title":"Crit. Care Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:55Z","timestamp":1760123755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/8\/7278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24087278"],"URL":"https:\/\/doi.org\/10.3390\/ijms24087278","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}